Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NPHC is audited by a 3rd party Auditing company. That should tell you that the theory presented is total BS.
If you followed the company on their NPHC Twitter page then clues would be seen.
I disagree with you.
what about your link about security case filed you mentioned? You post a site for filing a complaint but your post mentioned a complaint filed.
sec show no new complaints at all.
The data from the chart is from a major brokerage. It's real. I can get any shares available to short from any company.
Just Google the brokerages that get fined by the sec. There are many that do not report short info.
Also, the sec just reports what brokerages give them at the last day and hour of the reporting period. The sec report doesn't show what happened in that 15 day period at all. Hope that helps.
Where the link to this inquiry. You have the link right?
need to find what market maker made that trade. retail cant trade 6 digits after the decimal. more market maker manipulation.
someones been buying.
no joke. Just look at the prs.Things have been accomplished.
Here is what's coming from Deitsch and NPHC
Multiple Sclerosis Trials
Government Grants for validation of NPHC Nerve Agent Countermeasure
Adding to NPHC's 21 Patents
Additional Social Media Endorsements
New Products from NPHC
Here is what Deitsch the CEO has done for NPHC in 19 years:
Pink Current Status
Added Many patents and trademarks to Nutra's portfolio
Clinical Trials in Multiple Phases
1. Multiple Sclerosis Trials
2. Herpes Simplex Infections 1 & 2 Trials
3. Adrenomyeloneuropathy Trials
4. HIV Trials
5. Amyotrophic Lateral Sclerosis Trials
6. Rheumatoid Arthritis Trials
7. Pain Trials
Products launched and brought to Market
1. Cobroxin
2. Nyloxin
3. Pet Pain Away
4. Equine pain Away
5. Luxury Feet
Published Research
http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research
Increased Sales on Amazon and Walmart
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC
on the contrary, everyone knows you can short a penny stock. I've proven it numerous times with data from a real brokerage. denying the data is just plain wrong.
That was funny.
please provide proof. sounds like more non sense to me.
by claiming the loans are fake is also claiming the auditors are in on the scheme which is wayyyyyy to fn funny.
Your nphc targets are based on non sense.
I do not agree with you at all about nphc. Silence doesnt mean people arent here.
Numbers don't lie, 4 million shares shorted. You can see it on the increased volume that day on a chart.
good luck to your nphc investment.
Deitch just converted $500k into preferred shares. So anyone saying he is going to leave the company makes no sense at all.
Thats some of the craziest shit I've heard here. Talk about wild theories. So your thinking that because nphc is selling nyloxin thru another channel that somehow means rik is trying to make off with nyloxin. How do you even come to that accusation. So if nphc starts selling nyloxin in stores, that would mean the same thing to you.
And why would they do that? more useless non sense about deitsch leaving with absolutely no proof to back it up.
More non sense about deutsch exiting. Absolutely non sense.
You are only looking at preferred over common when you should be looking at preferred over creditors. Creditors have first pick. Glad I can continue to teach.
So you are saying that nphc will have enough money coming in for dividends. nice
Whole lot of wild theories there bud.
1) from pr it states nphc is making products for another company. That means sales revenue coming into nphc. very easy to figure out.
2) just a wild theory there as.avini is a separate private company thats ordering products to be made by nphc. Also rik converted $500,000 into preferred B nphc shares. if Rik wanted to take nphc's IP then Rik wouldnt have done this. thats just common sense.
I dont think its yearly as a yearly rate would says per annum. not just annum.
Not sure where or why you would think that?
I believe you are wrong and you know it.
what makes financing toxic are floorless convertibles. there are no floorless convertibles in nphc. this is proven by no large amounts of selling on the bid and then reloading at lower conversions.
saying friendly financing is toxic is just completely wrong.
You are wrong. Toxic financing are floorless convertibles where there are none with nphc. nice try.
I hate to break it to you but rik converting $500 thousand dollars into preferred shares shows the commitment he has to nphc.
There is no toxic financing here. There aren't floorless convertibles.
Thats authorized not oustanding. Theres a difference.
Because nothing with nphc gets done on your time frame doesnt mean things are not getting done. Rik is the CEO. not some armchair quarterback pretending to run a company.
Things don't develope overnight either. Try reading the what's coming from switch post. That will help you understand what the company has done in the last 20 years
I dont agree with you at all regarding nphc. time will tell.